BioCentury
ARTICLE | Clinical News

514G3: Completed Ph I/II enrollment

December 30, 2016 1:44 AM UTC

In December, XBiotech completed enrollment of 36 patients hospitalized with bacteremia due to S. aureus in the Phase II portion of a double-blind, placebo-controlled, international Phase I/II trial ev...

BCIQ Company Profiles

XBiotech Inc.